Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients

Gynecologic Oncology

Volumn 136, Issue 1, 2015, Pages 82-86

  Rithirangsriroj, Kulthida ^a   Manchana, Tarinee ^a   Akkayagorn, Lanchasak ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Acupuncture; Chemotherapy induced nausea and vomiting; Gynecologic cancer; Quality of life

Indexed keywords

CARBOPLATIN; CHLORPHENIRAMINE; DEXAMETHASONE; ONDANSETRON; PACLITAXEL; RANITIDINE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ACUPUNCTURE; ADD ON THERAPY; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DISEASE SEVERITY; DYSPEPSIA; ENDOMETRIUM CANCER; FALLOPIAN TUBE CANCER; FEMALE; GYNECOLOGIC CANCER; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEUM CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT DURATION; UTERINE CERVIX CANCER; CHEMICALLY INDUCED; GENITAL NEOPLASMS, FEMALE; MIDDLE AGED; NAUSEA; PROCEDURES; VOMITING;

ACUPUNCTURE THERAPY; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CROSS-OVER STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NAUSEA; ONDANSETRON; PACLITAXEL; VOMITING;

EID: 84925230060     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.10.025     Document Type: Article

References (14)

1. Grunberg SM. Chemotherapy-induced nausea and vomiting: prevention, detection and treatment - how are we doing? J Support Oncol 2004;2:1-20.
2. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Antiemesis; 2014 [Available at: http://www.nccn.org/professionals/physician-gls/PDF/antiemesis.pdf. Retrieved May 15, 2014].
3. Navari RM. Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents. Drugs 2013;73:249-62.
4. Manchana T, Worasethsin P, Tresukosol D. A randomized, double blinded comparison of single dose ondansetron and metoclopramide plus dexamethasone in the prevention of single agent carboplatin induced emesis in ovarian and endometrial carcinoma. Thai J Obstet Gynecol 2002;14:51-8.
5. Consensus NIH. Conference. Acupuncture. JAMA 1998;28:1518-24.
6. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2006;19(2):CD002285.
7. Hesketh PJ, Beck T, Uhlenhopp M, Kris MG, Hainsworth JD, Harker WG, et al. Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen. J Clin Oncol 1995;13:2117-22.
8. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
9. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010;21:232-43.
10. Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, et al. Antiemetic American Society Clinical Oncology clinical practice guideline update. J Clin Oncol 2011;29:4189-98.
11. Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol 2013;31: 952-60.
12. Bao T. Use of acupuncture in the control of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw 2009;7:606-12.
13. Streitberger K, Friedrich-Rust M, Bardenheuer H, Unnebrink K, Windeler J, Goldschmidt H, et al. Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial. Clin Cancer Res 2003;9:2538-44.
14. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 2006;24: 4472-8.